Seeking Alpha

Shares of Incyte (INCY +4.4%) rally with the help of a reiteration by analysts at Jefferies of a...

Shares of Incyte (INCY +4.4%) rally with the help of a reiteration by analysts at Jefferies of a Buy rating and the announcement that the firm is presenting positive results for its ruxolitinib treatment for various cancers at a Hematology conference today.
Comments (1)
  • jsandresen1
    , contributor
    Comments (25) | Send Message
     
    You should read this article prior to getting behind this stock. This part of the story is not going away. There are more patients not seeing positive results with Jakafi than are.

     

    http://bit.ly/AEyLvt
    5 Jan 2012, 12:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)